ABSTRACT
OBJECTIVES: To evaluate patterns of cannabis use in patients with cutaneous lymphoma (CL), as well as the association between cannabis use and itch specifically. DESIGN: Cross-sectional survey created in partnership with the Cutaneous Lymphoma Foundation (CLF). SETTING: The online survey was distributed electronically via email to the CLF listserv and links posted to social media over a 2-week period. MAIN OUTCOME MEASURES: Respondents were classified as current cannabis users, prior users, and never users. A visual analog scale (VAS) was used to assess itching severity, improvement of itch, and interest in learning about cannabis. RESULTS: A total of 119 patient responses (61% female, mean age 59 y) were included in analysis. The majority had mycosis fungoides or Sézary syndrome (74%; 88/119) and early stage (IA-IIA) disease (56%; 48/86). Mean VAS itch score was 3.2 + 2.8 for the cohort. Over half (55%; 60/110) reported ever having used cannabis, with 22% (24/110) endorsing current cannabis use. Common methods of cannabis use were smoking (54%) and vaporizing (46%). 25% (6/24) of current users reported using cannabis specifically to treat itch; these respondents noted that cannabis resulted in moderate improvement of itching (mean 6.6/10). There was strong interest in learning more about cannabis and cancer, and most desired this information from their CL doctor/nurse. CONCLUSIONS: Cannabis use is common among patients with CL, and patients report improvement of itching as a result of using cannabis. Further studies are needed to elucidate the risks and benefits of cannabis use in this patient population.
Subject(s)
Cannabis , Mycosis Fungoides , Skin Neoplasms , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Mycosis Fungoides/pathology , Pruritus/drug therapyABSTRACT
Fitzpatrick skin type (FST) was developed to assess the propensity of the skin to burn during phototherapy, but it also is commonly used by providers as means of describing constitutive skin color and ethnicity. We conducted an anonymous survey of dermatologists and dermatology trainees to evaluate how providers use FST in their clinical practice. Although providers should be cognizant of conflating race/ethnicity with FST, the original intent of FST also should be emphasized in medical school and resident education.
Subject(s)
Dermatologists , Internship and Residency , Skin Pigmentation , Sunburn/ethnology , Ethnicity , Humans , Surveys and QuestionnairesSubject(s)
Burnout, Professional/epidemiology , Dermatologists/psychology , Gender Identity , Parents/psychology , Physicians, Women/psychology , Work-Life Balance , Adolescent , Adult , Affective Symptoms/epidemiology , Affective Symptoms/etiology , Aged , Child , Child, Preschool , Dermatologists/statistics & numerical data , Ethnicity/psychology , Ethnicity/statistics & numerical data , Fatigue/epidemiology , Fatigue/etiology , Female , Humans , Infant , Infant, Newborn , Male , Marriage , Mental Disorders/epidemiology , Mental Disorders/etiology , Middle Aged , Physicians, Women/statistics & numerical data , Professional Practice/statistics & numerical data , Surveys and Questionnaires , United States/epidemiology , Young AdultABSTRACT
Phototherapy in skin of color requires special consideration. Pigmented skin is an efficient ultraviolet filter. Hence, higher doses of ultraviolet radiation are generally more effective and well tolerated in skin of color. An objective and practical system has not yet been established to determine optimal phototherapy dosing in skin of color. The authors recommend obtaining a detailed history of each individual patient's response to sun exposure before prescribing a phototherapy dosing regimen. In addition, providers should consider the role of socioeconomic factors and their impact on phototherapy-related outcomes, including barriers to access and compliance.
